Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.
According to Bumrungrad Hospital Public Company Limited's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.94. At the end of 2022 the company had a P/S ratio of 8.13.
Year | P/S ratio |
---|---|
2023 | 6.94 |
2022 | 8.13 |
2021 | 8.99 |
2020 | 7.59 |
2019 | 5.80 |
2018 | 8.84 |
2017 | 7.51 |
2016 | 7.36 |
2015 | 8.71 |
2014 | 6.57 |
2013 | 4.24 |
2012 | 4.17 |
2011 | 3.07 |
2010 | 2.30 |
2009 | 2.30 |
2008 | 1.74 |
2007 | 3.07 |
2006 | 3.41 |
2005 | 3.15 |
2004 | 1.81 |
2003 | 0.10 |